ArticlePediatric blood & cancer2020

Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium.

Jonathan Gill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.